Table 3 Microbial growth and antibiotic resistance profile for culture growth from sample 2, (n = 105)

Total sample

117

Anaerobes

16

Aerobes

101

Gram + ve (overall)

70/101

69.31

Gram -ve (overall)

31/101

30.69

Frequency of pathogens isolated from DFO patients in sample 2

Staphylococcus

38

36.19

Streptococcus

15

14.28

Enterococcus

11

10.47

Corynebacterium

4

3.81

Pseudomonas

3

2.85

E. coli

6

5.71

Proteus mirabilis

6

5.71

Candida

1

0.95

MRSA

1

0.95

Enterobacter cloacae

6

5.71

Dermabacter Hominis

1

0.95

Morganella Morganii

1

0.95

Citrobacter Freundii

2

1.9

Providencia Rettgeri

1

0.95

Klebsiella

4

3.81

Serratia

1

0.95

No pathogens isolated

16

15.23

Frequency of antibiotic resistance patterns identified (n = 105)

Total Sample

105

Clarithromycin

20

19.04

Erythromycin

5

4.76

Penicillin

8

7.61

Ciprofloxacin

10

9.52

Tazocin

5

4.76

Amoxicillin

11

10.47

Clindamycin

4

3.81

Ceftazidime

1

0.95

Doxycycline

8

7.61

Flucloxacillin

3

2.85

Trimethoprim

11

10.47

Co-amoxiclav

8

7.61

Meropenem

3

2.85

Gentamicin

5

4.76

Tigecycline

1

0.95

Cefotaxime

1

0.95

Co-trimoxazole

1

0.95

No resistance patterns identified

12